Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Proposals of the Shareholders’ Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2024 Annual General Meeting

Oriola Corporation Stock Exchange Release 24 January 2024 at 10:00 a.m. EET Proposals of the Shareholders’ Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2024 Annual General Meeting Oriola’s Shareholders’ Nomination Board has presented its proposal to the 2024 Annual General Meeting concerning the composition of the Board of Directors as follows: · The number of members of the Board of Directors would be seven · The present members of the Board of Directors Nina Mähönen, Yrjö Närhinen, Ellinor Persdotter Nilsson, Harri Pärssinen

Invitation to Tobii Dynavox’s webcast following the 2023 year-end report

Tobii Dynavox will publish the 2023 year-end report on February 8 at 7.30 a.m. CET. Following this report, at 9.00 a.m. CET, Tobii Dynavox will host a presentation for investors, analysts and media.    Tobii Dynavox’s President and CEO Fredrik Ruben and CFO Linda Tybring will present and comment on the report. The presentation will be held in English and can be viewed as a live webcast. After the main presentation, a Q&A session will follow where the participants are welcome to ask questions by using the online chat function. If you wish to ask questions verbally, contact CFO Linda

Loomis AB to publish full-year report on January 31, 2024

Loomis AB will publish the full-year report January-December 2023 on Wednesday January 31, at 7:30 a.m. (CET).Agenda   7.30 a.m. (CET) - Report release The report will be sent as a press release from Cision (www.cision.se) and will automatically be published on www.loomis.com when released.   8:00 a.m. (CET) - Presentation slides available For presentation slides, go to www.loomis.com and choose “Financial presentation”.   10.00 a.m. (CET) – Telephone conference and audio cast Analysts and media are invited to participate in a telephone conference at 9:00 a.m.

Renowned Gastroenterologist, Dr. Adam S. Cheifetz, Joins AegirBio’s Scientific Advisory Board

AegirBio AB announces the appointment of Dr. Adam S. Cheifetz to its Scientific Advisory Board.Dr. Cheifetz, Director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School, brings unparalleled expertise in the field of gastroenterology, particularly in the treatment of Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases. "We are honoured to welcome Dr. Cheifetz to our Scientific Advisory Board. His extensive knowledge, ground-breaking research, and leadership in the field of

Himalaya Shipping Ltd. (HSHP) – Special General Meeting Results Notification

Himalaya Shipping Ltd. (the “Company”) advises that a Special General Meeting of the Company was held on January 23, 2024 at 10:00 local time, at the Registered Office of the Company, 2nd Floor, S.E. Pearman Building, 9 Par-la-Ville Road, Hamilton HM 11, Bermuda. The following resolution was approved by the Company’s shareholders: “To reduce the Share Premium account of the Company from US$97,876,367.66 to US$0 by the transfer of US$97,876,367.66 of the Share Premium to the Company’s Contributed Surplus account, with effect from January 23[rd], 2024.” The Board of Directors

Transcom to offer high-end customer experience from India through the acquisition of VCosmos

Transcom, the global AI powered CX challenger, today signed a letter of intent to acquire VCosmos, a high-end CX solution provider in India. VCosmos serves clients across North America, Asia, and Europe through voice, email, chat, and social media channels in their customer experience centers in Gurgaon and Jaipur, and their rapidly growing work-at-home network. They employ 700 people and can rapidly scale both voice and non-voice multi-lingual and multi-channel CX services. “We’ve been excited by India for some time, as the country provides an unbeatable combination of a scalable and

Fazer Bakery’s tasty new products for the spring – many ways to enjoy wholegrain and cakes that are ready to serve after defrosting

At the end of January, delicious new flavours will take over shops across the country, when Fazer Bakery is launching a variety of fibre-rich and tasty breads. The novelty selection also includes gluten-free Reissumies, gorgeous Pullava buttery buns and mouth-watering cakes made from Fazer’s sweets Pätkis and Fazerina. The in-store bake-off units will have a new, cheesy snack.Fazer Puikula Kuiturikas Kaura (fibre-rich oat bread) 6 pcs 330 g The porridge that forms the basis of the bread dough gives the bread a soft and rich structure that feels fresh for several days. In addition to its

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseJanuary 24, 2024 at 9.30 am EETRepurchase of Outokumpu’s own shares On January 23, 2024, Outokumpu has completed repurchases of its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |96,232 |3.9647

Medivir to present at the Redeye Fight Cancer Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Fight Cancer Day, today January 24, 2024.   CEO Jens Lindberg will present the company and updated data from the ongoing phase 1b/2a clinical study with fostroxacitabine bralpamide (fostrox) at 15.20 CET. The presentation is live broadcasted and can be followed at the event page; https://www.redeye.se/events/966280/redeye-theme-fight-cancer-2

Quarterly Report I 23/24

September 2023 – November 2023, Diamyd Medical AB (publ), Fiscal year 2023/2024Precision Medicine for Autoimmune Diabetes in Pivotal Phase 3Diamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com September 1, 2023 – November 30, 2023 · Operating income: MSEK 1.0 (1.0) · Net result: MSEK -32.8 (-33.0) · Result per share: SEK -0.4 (-0.4) · Cash flow from operating activities: MSEK -27.8 (-27.1) · Cash and short-term investments at November 30, 2023: MSEK 176.7 (130.9)

Invitation to a press and analyst conference in Stockholm for the presentation of Concentric’s Fourth Quarter 2023 results

Concentric's Interim Report for Q4 2023 (January-December 2023), will be published on the 7th of February  2024, at 08.00 CET. At 10.00 CET media, investors and analysts are invited to Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm, for a presentation of the report. There will also be an opportunity to participate via webcast/telephone conference. President & CEO Martin Kunz and CFO Marcus Whitehouse will host the presentation, which will be held in English and is followed by a Q&A-session. We look forward to your participation. Please see the below detailed information to

Flagship Biosciences and Offspring Biosciences Partner to Provide Complete Global Assay Development Services from Target Identification to Companion Diagnostics

Unlocking the combined value of Offspring’s innovative pre-clinical solutions with Flagship’s clinical trial data-driven assay solutions Broomfield, CO, USA and Södertälje, Sweden – January 24, 2024 – Flagship Biosciences, a leader in spatial biology and biomarker analytics services, and Offspring Biosciences, an innovator in pre-clinical biomarker assay solutions, today announced a strategic partnership that aims to further advance precision drug development with a complete biomarker offering from discovery to companion diagnostics development.The partnership allows both companies to

Handelsbanken’s year-end report for January – December 2023 will be presented Wednesday 7 February

Handelsbanken publishes its year-end report for January ­– December 2023, at 07:00 a.m. CET Wednesday, 7 February. The report, slide presentation and Fact Book will be published on handelsbanken.com/ir. The President and Group Chief Executive Officer Michael Green will present the year-end report at 09:00 a.m. CET. The presentation will be broadcast live in Swedish and available at handelsbanken.com/ir and with the option for simultaneous interpretation into English. The presentation will be followed by a short break, after which a Q&A session will be held in English for analysts,

Equity Issuance

For Immediate Release 24 January 2024 ROGUE BARON PLC (“Rogue Baron” or “the Company”) Equity Issuance Rogue Baron PLC (AQSE: SHNJ), a leading company in the premium spirit sector, announces that it has issued 3,928,571 ordinary shares to certain consultants and creditors of the Company. Admission to Aquis Growth Market Application will be made for the 3,928,571 new ordinary shares to be admitted to trading on the Aquis Growth Market ("Admission"). It is expected that Admission of the new ordinary shares will become effective at 8.00 a.m. on or around 29 January 2024.

Storytel sharpens focus on profitability on the back of strong Q4 2023 earnings and upgrades mid-term financial targets - announces efficiency initiative and write-downs

· Storytel sharpens its focus on profitability and will improve cash flow generation beyond the previously outlined guidance at the Capital Markets Day in June 2023. An efficiency optimization initiative will be implemented during the first quarter of 2024, including a 13% reduction in workforce.   · As a result of increased emphasis on profitability and reduced growth investments in certain markets, related assets will not generate as much cash flow as previously planned. For that reason a non-cash write down of 632 MSEK will be recorded in the fourth quarter of 2023. 465 MSEK of the

Proposal of the Shareholders’ Nomination Board for the composition and remuneration of Tokmanni Group’s Board of Directors

Tokmanni Group Corporation        Stock exchange release        24 January 2024 at 9:00 amThe Shareholders’ Nomination Board of Tokmanni Group Corporation proposes to the Annual General Meeting that the number of the members of the Board of Directors remains the same and be six. The Nomination Board proposes that the current members of the Board of Directors Seppo Saastamoinen, Harri Sivula, Erkki Järvinen, Ulla Serlenius and Mikko Bergman will be re-elected. The Nomination Board also proposes that Eja Tuominen will be elected as a new member to the Board of Directors. Current Member of

Inside Information: Changes in Bittium Corporation’s Management Group

Bittium CorporationInside information Inside Information: Changes in Bittium Corporation’s Management Group Bittium Corporation, Stock Exchange Release, January 24, 2024, at 9:00 am (CET+1) Antti Näykki, Senior Vice President, Medical Business Segment, Bittium Corporation (Engineer, Embedded Systems) has been appointed as Vice President, Group Business Development as of February 1, 2024. He will continue as a member of Bittium Corporation's management group. In this role, Näykki will focus on building Bittium's long-term growth. He will also be responsible for the management of

Expert Tips for 2 weeks guide in Thailand

The Tourism Authority of Thailand's Stockholm office was delighted to engage in an insightful discussion with Towe Ahlin from Come Fly with Me , an experienced travel blogger, to uncover the secrets to Thai adventure. With her numerous travels across Thailand, Towe's knowledge and recommendations are invaluable for anyone seeking a meaningful experience in Thailand. Our goal is to ensure that every traveler embarks on a journey that surpasses their expectations whether you're a first-time visitor or regular Thailand’s explorer.When is a good time to travel to

Expert Tips for 2 weeks guide in Thailand

The Tourism Authority of Thailand's Stockholm office was delighted to engage in an insightful discussion with Towe Ahlin from Come Fly with Me , an experienced travel blogger, to uncover the secrets to Thai adventure. With her numerous travels across Thailand, Towe's knowledge and recommendations are invaluable for anyone seeking a meaningful experience in Thailand. Our goal is to ensure that every traveler embarks on a journey that surpasses their expectations whether you're a first-time visitor or regular Thailand’s explorer.When is a good time to travel to

Transaction in Own Shares

    24 January 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |23/01/2024|+-----------------------------------------------------------

WntResearch's co-founder applies for subscription of additional units in the ongoing rights issue with a last day for subscription on 29 January 2024

Tommy Andersson, co-founder and board member of WntResearch AB ("WntResearch" or the "Company"), has applied for subscription of additional units in the rights issue that was announced through a press release on 20 November 2023 (the "Rights Issue"). In addition, several of the Company's existing larger shareholders have also announced their intention to subscribe for more units than what they have committed to in advance by agreement.Tommy Andersson has, through a company and without the support of unit rights, applied for additional subscription of units in the Rights Issue with SEK 118,

Skanska builds power projects in Vestland County, Norway, for NOK 1.9 billion, about SEK 1.9 billion

Skanska has signed a contract with Aker BP for the construction of a transformer station and a compensation station in Vestland County, Norway. The contract is worth NOK 1.9 billion, about SEK 1.9 billion, which will be included in the Nordic order bookings for the first quarter 2024.The contract consists of both building and construction work related to a new transformer station in Børdalen in Samnanger municipality, as well as a compensation station at Årskog in Fitjar municipality. The construction works is ongoing, and the project is expected to be completed during the autumn 2025.

Uniwater acquires Lauridsen – expands in water and wastewater sector in the Danish market

Uniwater, the Nordic water and wastewater infrastructure group, has acquired Danish water and wastewater specialist Lauridsen. Lauridsen has operations in Denmark and Poland and an experienced team of water infrastructure specialists in both markets. The acquisition strengthens Uniwater’s expertise and presence on the Nordic and European markets.Uniwater, today consisting of 13 companies in Sweden, Norway and Finland, today announced the acquisition of Lauridsen, one of Denmark’s leading suppliers of components, technical solutions and consultancy services within water and wastewater

Norse Atlantic ASA: Last day of the subscription period in the subsequent offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Arendal, 24 January 2024: Reference is made to the stock exchange announcement published by Norse Atlantic ASA (the "Company") on 11 January 2024 regarding the approval and publication of the Prospectus (as defined below), and the launch of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top